UBS Maintains Neutral on Cabot, Lowers Price Target to $92

Cabot Corporation

Cabot Corporation

CBT

0.00

UBS analyst Joshua Spector maintains Cabot (NYSE: CBT) with a Neutral and lowers the price target from $97 to $92.